For the first time since the 1970's, a small group of Canadians have been granted (federal) permission to legally use psilocybin for medicinal purposes.
For the first time since the 1970's, a small group of Canadians have been granted (federal) permission to legally use psilocybin for medicinal purposes.
MindMed adds a psychedelics therapy expert to its LSD research program.
LEGAL use of psilocybin in Canada for the first time in nearly 50 years.
Mydecine's Vancouver-based affiliate, Mindleap Health™ is adding three digital therapy programs.
The need for the medicinal benefits of psychedelic drugs is producing unlikely allies.
Novamind acquires Utah-based Cedar Psychiatry and Cedar Clinical Research for CAD$3.05 million.
More pressure on Ottawa to move forward on legalization of psilocybin.
Big Pharma has strong incentives to embrace psychedelics. But will its predatory business model turn drug companies against these drugs?
Numinus establishes a partnership with one of Canada's largest addiction treatment organizations.
MindMed completes its Phase 1 study of its non-hallucinogenic formulation of ibogaine.
Psychedelics Have Proven Potential To Disrupt Entire Mental Healthcare Industry
Get Your Guide To “Ground Floor” Opportunity In Psychedelic Stocks Now